The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) is holding an end-of-program event on March 1, in Arlington, VA.
We’ll be discussing progress made toward ensuring that quality, life-saving essential medicine and services are available and affordable to those who need them. We’ll also explore goals and challenges for the future of pharmaceutical systems strengthening and advance a vision of what it takes to build resilient, responsive pharmaceutical systems that promote good health outcomes.
The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, led by Management Sciences for Health (MSH), in collaboration with the Stop TB Partnership Global Drug Facility, will host a technical conference titled, “Building the Post-2015 Agenda: Novel Approaches to Improving Access to TB Medicines and Pharmaceutical Services” from March 2-6, 2015 at the Conrad Bangkok Hotel in Bangkok, Thailand.
Join MSH at the Third Global Symposium on Health Systems Research in Cape Town, South Africa from September 30th – October 3rd! We will be participating in multiple sessions throughout the week to participate in the presentations and discussions of people-centered health systems. Visit us at booth 21 in the Marketplace and follow our conference blog on Twitter and Facebook for live updates from Cape Town.
We are hosting two satellite sessions on Monday, September 29th. Click here to register.
Fighting Drug-Resistant TB in the 21st Century: Novel Approaches to Improving Access to anti-TB Medicines and Pharmaceutical Services
1st Conference on Pharmaceutical Management for TB and M/XDR-TB for WHO European Region
Health systems stengthening drives our response to the tuberculosis epidemic. In over 30 countries MSH is working with international, national, and local partners to strengthen the capacity of health systems, national TB programs, and health managers to improve the lives of those affected by TB and prevent the spread of disease. Our work addresses all elements of the health system: service delivery; leadership and governance; medical products, vaccines, and technologies; health financing; health information; and human resources.